Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 22828781)

1.

The pan-genotype specificity of the hepatitis C virus anti-core monoclonal antibody C7-50 is contingent on the quasispecies profile of a population.

Palmer BA, Menton J, Levis J, Kenny-Walsh E, Crosbie O, Fanning LJ.

Arch Virol. 2012 Nov;157(11):2235-9. doi: 10.1007/s00705-012-1418-4. Epub 2012 Jul 25.

PMID:
22828781
2.

Characterization of three novel monoclonal antibodies against hepatitis C virus core protein.

Moradpour D, Wakita T, Tokushige K, Carlson RI, Krawczynski K, Wands JR.

J Med Virol. 1996 Mar;48(3):234-41.

PMID:
8801283
3.

Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.

Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, El-Zayadi A, Hamid S, Dusheiko GM, Saeed AA, Haydon GH, Simmonds P.

J Clin Microbiol. 1997 Dec;35(12):3062-70.

4.

Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.

Chuang WC, Allain JP.

J Gen Virol. 2008 Aug;89(Pt 8):1890-900. doi: 10.1099/vir.0.83677-0.

5.

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kuzuya T, Honda T, Hayashi K, Nakano I, Katano Y, Goto H.

Clin Infect Dis. 2005 Mar 15;40(6):e49-54. Epub 2005 Feb 18.

9.

Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.

Muerhoff AS, Gutierrez R, Kyrk C, Leary T, Schlauder G, Dawson G, Desai SM.

J Med Virol. 2008 Mar;80(3):411-8. doi: 10.1002/jmv.21082.

PMID:
18205228
10.

Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.

Pujol FH, Khudyakov YE, Devesa M, León G, Blitz-Dorfman L, Monsalve F, Lambert SB, Kalinina TY, Liprandi F, Fields HA.

Viral Immunol. 1996;9(2):89-96.

PMID:
8822625
11.

Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.

Budkowska A, Kakkanas A, Nerrienet E, Kalinina O, Maillard P, Horm SV, Dalagiorgou G, Vassilaki N, Georgopoulou U, Martinot M, Sall AA, Mavromara P.

PLoS One. 2011 Jan 6;6(1):e15871. doi: 10.1371/journal.pone.0015871.

12.

Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.

Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, Spengler U, Weis N, Bukh J.

J Virol. 2011 Mar;85(6):2891-906. doi: 10.1128/JVI.01605-10. Epub 2010 Dec 22.

13.

Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A.

J Virol. 2001 Sep;75(17):8240-50.

14.

Antigenic relevance of F protein in chronic hepatitis C virus infection.

Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, Van Roosmalen M, Pol S, Negro F, Paranhos-Baccalà G.

Hepatology. 2004 Oct;40(4):900-9.

PMID:
15382175
15.

Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.

Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.

Mol Immunol. 2006 Feb;43(5):436-42. Epub 2005 Apr 2.

PMID:
16337486
16.

Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.

Ferns RB, Tuke PW, Sweenie CH.

J Med Virol. 1996 Nov;50(3):221-9.

PMID:
8923286
17.

A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.

Cerino A, Boender P, La Monica N, Rosa C, Habets W, Mondelli MU.

J Immunol. 1993 Dec 15;151(12):7005-15.

PMID:
7505020
18.

Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.

Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R.

Dig Dis Sci. 2007 Sep;52(9):2427-32. Epub 2007 Apr 10.

PMID:
17436105
19.
20.

A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.

Kmieciak D, Biernacka-Lukanty J, Migdalski P, Turek-Plewa J, Wierzbicki A, Juszczyk J, Trzeciak WH.

Acta Virol. 2005;49(2):97-103.

PMID:
16047736
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk